FR2356424B1 - - Google Patents

Info

Publication number
FR2356424B1
FR2356424B1 FR7720100A FR7720100A FR2356424B1 FR 2356424 B1 FR2356424 B1 FR 2356424B1 FR 7720100 A FR7720100 A FR 7720100A FR 7720100 A FR7720100 A FR 7720100A FR 2356424 B1 FR2356424 B1 FR 2356424B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7720100A
Other versions
FR2356424A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astra Lakemedel AB
Original Assignee
Astra Lakemedel AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20328354&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2356424(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Lakemedel AB filed Critical Astra Lakemedel AB
Publication of FR2356424A1 publication Critical patent/FR2356424A1/fr
Application granted granted Critical
Publication of FR2356424B1 publication Critical patent/FR2356424B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3886—Acids containing the structure -C(=X)-P(=X)(XH)2 or NC-P(=X)(XH)2, (X = O, S, Se)
    • C07F9/3891—Acids containing the structure -C(=X)-P(=X)(XH)2, (X = O, S, Se)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7720100A 1976-07-01 1977-06-30 Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales Granted FR2356424A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7607496A SE7607496L (sv) 1976-07-01 1976-07-01 Sett for bekempning av virusinfektioner

Publications (2)

Publication Number Publication Date
FR2356424A1 FR2356424A1 (fr) 1978-01-27
FR2356424B1 true FR2356424B1 (fr) 1980-04-18

Family

ID=20328354

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7720100A Granted FR2356424A1 (fr) 1976-07-01 1977-06-30 Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales

Country Status (22)

Country Link
US (4) US4215113A (fr)
JP (1) JPS536428A (fr)
AT (1) AT369014B (fr)
AU (1) AU510809B2 (fr)
BE (1) BE856355A (fr)
BG (1) BG60834B2 (fr)
CA (1) CA1077848A (fr)
CH (1) CH641471A5 (fr)
DE (1) DE2728685C2 (fr)
DK (1) DK288877A (fr)
FI (1) FI772030A (fr)
FR (1) FR2356424A1 (fr)
GB (1) GB1585615A (fr)
HK (1) HK28984A (fr)
IE (1) IE45753B1 (fr)
LU (2) LU77666A1 (fr)
MX (1) MX9203635A (fr)
MY (1) MY8500125A (fr)
NL (2) NL180068C (fr)
NO (1) NO772299L (fr)
SE (1) SE7607496L (fr)
SG (1) SG80383G (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK564378A (da) * 1977-12-22 1979-06-23 Astra Laekemedel Ab Fremgangsmaade til fremstilling af amidderivater til bekaempelse af virusinfektioner
CA1140049A (fr) * 1977-12-22 1983-01-25 Dke J.E. Helgstran Substances pharmaceutiques obtenues a partir de derives d'acide hydroxycarbonylphosphonique
DE2926799A1 (de) * 1979-07-03 1981-01-15 Bayer Ag Phosphonoameisensaeurehydrazide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2941384A1 (de) * 1979-10-12 1981-04-23 Bayer Ag, 5090 Leverkusen Phosphono-hydroxy-essigsaeure, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
JPS59500317A (ja) * 1982-02-12 1984-03-01 シンテツクス　（ユー・エス・エイ）　インコーポレイテツド 抗ウイルス性組成物
JPH0761814B2 (ja) * 1984-09-10 1995-07-05 三菱化学株式会社 搬送装置
JPS6194925A (ja) * 1984-10-12 1986-05-13 Mitsubishi Chem Ind Ltd 搬送用装置
JPS61217434A (ja) * 1985-03-20 1986-09-27 Mitsubishi Chem Ind Ltd 搬送用装置
GB8501374D0 (en) * 1985-01-18 1985-02-20 Wellcome Found Treatment of aids
US4880619A (en) * 1985-03-11 1989-11-14 Colgate-Palmolive Company Anticalculus oral composition
US4590064A (en) * 1985-03-11 1986-05-20 Colgate-Palmolive Company Anticalculus oral composition
GB8512330D0 (en) * 1985-05-15 1985-06-19 Wellcome Found Antiviral compounds
US4806532A (en) * 1985-10-08 1989-02-21 Mayo Foundation For Medical Education And Research Inhibition of epithelial phosphate transport
AU5014285A (en) * 1985-10-21 1987-05-05 Sergio, W. Method for reducing the risk or probability of infection fromthe aids virus (htlv-iii/lav/arv)
US6492352B1 (en) * 1985-10-31 2002-12-10 Astra Lakemedel Aktiebolag Method for the control and treatment of acquired immunodeficiency syndrome (AIDS)
US5194654A (en) * 1989-11-22 1993-03-16 Vical, Inc. Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
US5463092A (en) * 1989-11-22 1995-10-31 Vestar, Inc. Lipid derivatives of phosphonacids for liposomal incorporation and method of use
US6110901A (en) * 1990-07-03 2000-08-29 American Cyanamid Company Method for treating RNA viral infections by using RNA chain terminators
SE9403861D0 (sv) * 1994-11-09 1994-11-09 Astra Ab Novel medicinal use
US5696277A (en) * 1994-11-15 1997-12-09 Karl Y. Hostetler Antiviral prodrugs
CA2223874A1 (fr) * 1995-06-06 1996-12-12 The University Of Southern California Procedes et compositions servant a inhiber la replication du cytomegalovirus
US7517858B1 (en) 1995-06-07 2009-04-14 The Regents Of The University Of California Prodrugs of pharmaceuticals with improved bioavailability
FI980216A0 (fi) * 1998-01-30 1998-01-30 Bene Pharma Oy Medicin foer behandling av vaorfor
US20040002079A1 (en) * 1998-02-11 2004-01-01 Gunn Robert B. Sodium-phosphate cotransporter in lithium therapy for the treatment of mental illness
DE19940748A1 (de) * 1999-08-27 2001-03-01 Hugo Seinfeld Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide
US7790159B2 (en) * 2002-07-15 2010-09-07 Board Of Regents, The University Of Texas System Methods, combinations and kits for treating viral infections using immunoconjugates and antibodies to aminophospholipids
US20040131622A1 (en) * 2002-07-15 2004-07-08 Board Of Regents Combinations and kits for treating viral infections using immunoconjugates to aminophospholipids
US7455833B2 (en) * 2002-07-15 2008-11-25 Board Of Regents, The University Of Texas System Methods and compositions for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7611704B2 (en) * 2002-07-15 2009-11-03 Board Of Regents, The University Of Texas System Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7906115B2 (en) 2002-07-15 2011-03-15 Thorpe Philip E Combinations kits and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
EP1603542A1 (fr) * 2003-03-14 2005-12-14 Epistem Limited Traitement et/ou prevention d'une deterioration epitheliale non virale
US7424812B2 (en) 2003-05-16 2008-09-16 Stanton Concepts Inc. Multiple function lock
US20090214676A1 (en) 2005-04-30 2009-08-27 Tissuetech, Inc. Method for treating ocular demodex
US20080045482A1 (en) * 2006-01-27 2008-02-21 Adventrx Pharmaceuticals, Inc. Compositions and methods for the treatment of viral infections
US8128968B2 (en) * 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations
US9006219B2 (en) * 2008-03-12 2015-04-14 Nektar Therapeutics Oligomer-foscarnet conjugates
ES2578902B1 (es) * 2014-12-29 2017-07-07 Agencia Pública Empresarial Sanitaria Costa Del Sol Uso de análogos del ión pirofosfato para el tratamiento de la infección por VPH
WO2022153334A1 (fr) * 2021-01-15 2022-07-21 Jubilant Generics Ltd Formes galéniques transmucosales du foscarnet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767795A (en) * 1971-02-25 1973-10-23 Abbott Lab Method for combating certain virus infection
US3836650A (en) * 1971-02-25 1974-09-17 Abbott Lab Method for combating marek's disease in poultry
DE2360797C2 (de) * 1973-12-06 1985-05-23 Henkel KGaA, 4000 Düsseldorf Pharmazeutische Präparate

Also Published As

Publication number Publication date
JPS536428A (en) 1978-01-20
US4215113A (en) 1980-07-29
ATA465477A (de) 1982-04-15
NL180068C (nl) 1987-01-02
AU510809B2 (en) 1980-07-17
AT369014B (de) 1982-11-25
US4771041A (en) 1988-09-13
SG80383G (en) 1984-08-03
IE45753B1 (en) 1982-11-17
DK288877A (da) 1978-01-02
BE856355A (fr) 1978-01-02
DE2728685A1 (de) 1978-01-12
HK28984A (en) 1984-04-06
IE45753L (en) 1978-01-01
LU77666A1 (fr) 1977-10-07
LU88310I2 (fr) 1994-05-04
NL930053I2 (nl) 1994-01-03
DE2728685C2 (de) 1982-09-16
FI772030A (fr) 1978-01-02
NL7707235A (nl) 1978-01-03
SE7607496L (sv) 1978-01-02
CH641471A5 (de) 1984-02-29
NO772299L (no) 1978-04-25
NL930053I1 (nl) 1993-09-01
BG60834B2 (bg) 1996-04-30
CA1077848A (fr) 1980-05-20
AU2650577A (en) 1979-01-04
GB1585615A (en) 1981-03-11
MX9203635A (es) 1992-09-01
NL180068B (nl) 1986-08-01
FR2356424A1 (fr) 1978-01-27
US4665062A (en) 1987-05-12
US4339445A (en) 1982-07-13
JPS562046B2 (fr) 1981-01-17
MY8500125A (en) 1985-12-31

Similar Documents

Publication Publication Date Title
FR2356424B1 (fr)
FR2349111B1 (fr)
FR2349112B1 (fr)
FR2343484B1 (fr)
JPS613001B2 (fr)
FR2342530B1 (fr)
JPS5339698B2 (fr)
JPS533356U (fr)
JPS5610799Y2 (fr)
JPS5515631B2 (fr)
JPS5643149B2 (fr)
JPS5388112U (fr)
JPS52144601U (fr)
JPS53105079U (fr)
JPS5621738Y2 (fr)
JPS562573B2 (fr)
JPS52150410U (fr)
JPS52100201U (fr)
JPS5394103U (fr)
CH606019A5 (fr)
CH610432A5 (fr)
CH610077A5 (fr)
CH607047A5 (fr)
CH607119A5 (fr)
CH607232A5 (fr)

Legal Events

Date Code Title Description
CP Supplementary protection certificate (spc) filed

Free format text: PRODUCT NAME: FOSCARNET SODIUM HEXAHYDRATE; NAT. REGISTRATION NO/DATE: NL 17545 19910412; FIRST REGISTRATION: DK - 6705 19890303

Spc suppl protection certif: 93C0016

Filing date: 19930611

CP Supplementary protection certificate (spc) filed

Free format text: 93C0016, 930611

CR Request for supplementary protection certificate laid open to the public (eec regulation of 18 june 1992)

Free format text: 93C0016, 930611

CY Supplementary certificate of protection granted (eec regulation of 18 june 1992)

Free format text: 93C0016, 930611, EXPIRES:20020629